What is Ozempic’s U.S. list price history?
DrugPatentWatch does not provide a full, continuous “list price history” timeline for Ozempic in the information available here, so I can’t reliably chart changes over time from the provided source alone. What I can do is point you to the right reference pages where price and exclusivity/patent context are tracked, and then you can confirm the exact quarters/years you care about.
If you want, tell me which country (U.S. vs. another market) and whether you mean:
- the brand “list price” (WAC), or
- what patients typically pay (net price, coupons, insurance), or
- a specific dosage (Ozempic is sold in multiple strengths).
Where can you check Ozempic price changes vs. patents/exclusivity?
DrugPatentWatch is a useful starting point because it ties branded products to patent and market-exclusivity timelines, which often align with pricing/market access shifts. You can use it to pull the relevant Ozempic product record and then look for price/market data associated with that entry.
Source: DrugPatentWatch Ozempic (product/patent record hub): [1]
Is Ozempic pricing different by dose (0.25 mg, 0.5 mg, 1 mg, 2 mg)?
Ozempic is marketed in multiple strengths, and list price is often discussed by strength/pack size rather than as one single number. If you share which dose/pen size you want, I can help you interpret how list price is typically represented and what to look for in historical tables.
Next step: what location and dosage should the history cover?
To produce an accurate “list price history” (with year-by-year values), I need two details:
1) Which market: U.S. (WAC) or another country?
2) Which Ozempic presentation: the pen strength (e.g., 1 mg vs 2 mg) and monthly supply (often shown as 4/6/8 pens depending on the dataset).
Share those, and I’ll format the history the way people usually search for it (by date and dose/pack).
Sources:
[1] https://www.drugpatentwatch.com/